Document is current
Any future updates will be listed below
-
Authors
Wickman, Isac
Lövestam-Adrian, Monica
Granstam, Elisabet
Kjellström, Ulrika
Schroeder, Marion
-
Funding
Funding for this research was provided by:
Lund University
- License Information
-
More Information
Article History
Received: 11 September 2023
Accepted: 24 January 2024
First Online: 30 January 2024
Declarations
:
: The study was conducted in accordance with the tenets of the Declaration of Helsinki and was approved by the Ethics Board of Lund University. The Swedish Macula Register (SMR) was launched online in 2008 and today includes data on about 85% of all eyes treated for nAMD in Sweden. Data were obtained from the SMR after approval from its Steering Committee. Informed consent was obtained from all participants.
: Not applicable.
: MLA is a consultant for Novartis, Bayer AG, Allergan, Roche. She has received funding from Bayer AG and Novartis. EG is/has been a member of advisory boards for Novartis, Bayer AG, Roche. She has held lectures for and received fees from Novartis, Bayer AG, Allergan, Novo Nordisk. MS is a consultant for and has received funding from Bayer AG. IW and UK report no competing interests.
